Form 4: Hims & Hers CFO Sells Shares Under 10b5-1 Trading Plan

Hims & Hers Health, Inc. CFO, Oluyemi Okupe, sold 4,213 shares of Class A Common Stock at an average price of $29.9829 per share on December 26, 2024, under a pre-arranged 10b5-1 trading plan.

Summary

• Oluyemi Okupe, the Chief Financial Officer of Hims & Hers Health, Inc., sold 4,213 shares of Class A Common Stock on December 26, 2024.
• The sale was executed at an average price of $29.9829 per share.
• The transaction was conducted under a Rule 10b5-1 trading plan adopted by Mr. Okupe on May 31, 2024.
• Following the transaction, Mr. Okupe directly owns 128,365 shares of Class A Common Stock.
• The shares were sold at varying prices between $29.95 and $30.02.

Sentiment

Score: 5

Explanation: The document is a routine disclosure of an insider stock sale under a pre-arranged plan. It doesn't indicate any positive or negative sentiment about the company's performance or future prospects.

Risks

• Sales by company insiders can sometimes be perceived negatively by the market, potentially impacting the stock price.

Industry Context

Insider trading activity is a common occurrence in publicly traded companies, and the use of 10b5-1 plans is a standard practice to avoid accusations of trading on non-public information. This filing is a routine disclosure of such activity.

Comparison to Industry Standards

• The use of a 10b5-1 trading plan is a common practice among executives at publicly traded companies, including those in the healthcare and technology sectors, such as Teladoc Health and GoodRx.
• The volume of shares sold is relatively small compared to the total outstanding shares of Hims & Hers, and is not unusual for insider transactions.
• The price range of the sale is within the typical daily trading range of the stock, suggesting no unusual market impact.

Stakeholder Impact

• The sale of shares by a company executive may cause some short-term fluctuations in the stock price, but the long-term impact is likely to be minimal.

Key Dates

Keywords

insider trading, Form 4, 10b5-1 plan, stock sale, Hims & Hers, Oluyemi Okupe, CFO, equity securities